Erynn Gordon

Vice President of Clinical Operations

Genome Medical, Inc.

Erynn is a board-certified genetic counselor with expertise in clinical care, research and laboratory genetics. A leader in the genetic counseling community, Erynn has served as President of the American Board of Genetic Counseling and on the National Society of Genetic Counselors Board of Directors. Prior to joining Genome Medical, Erynn was the first genetic counselor at 23andMe, serving as Director of Clinical Affairs. She previously managed a precision medicine study at at the Coriell Institute for Medical Research and held clinical roles at University of Maryland School of Medicine and Children’s National Medical Center.

Speaker Questionnaire

What are your top priorities for employee health and well-being in 2022?

What are the most innovative programs that you will focus on in 2022 and 2023?

Looking at our three moonshots surrounding costs, culture, and care, which do you align with the most? What are you doing in this area?

If you could automatically receive a 25% reduction in costs in three areas/programs, what would your dream list be?

Is there an area where you were able to either create savings or stop costs from rising?

Are you doing anything to reimagine corporate culture and wellbeing?

If there were two physical solutions that could be turned into virtual or remote care instead, what would those be?

If you look at our 3 Moonshots - Costs, Culture, and Care; In one sentence, tell us what would be something positive for us to take from 2020 and bring into this new year?

Sessions Speaking

No items found.

1 Conference. 3 Moonshots.

Remember the mission to reach the moon? In 1962, President JFK set forth a vision. He initiated a movement that outlived him! Even in his death, the mission was accomplished seven years after his famous speech. Now we’re on a five-year mission, and it's not about us. This is a mission for you – the individual, the stakeholder, the employer healthcare and benefits professional. Join the mission to reduce costs, reimagine culture, and reinvent care.